NCT07389577 A Study to Compare JL14002 to Lucentis® in Subjects With Wet Age-related Macular Degeneration (wAMD) Status COMPLETED Phase PHASE3
NCT07338513 User-centric Study of Patients' Receptiveness Towards the Web-based Automated Vision Impairment Gaze-tracking Analysis Systems Status NOT_YET_RECRUITING Phase N/A
NCT07178249 Evaluating the Safety and Preliminary Efficacy of EXG202 Gene Therapy for Neovascular AMD Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06952452 Pharmacogenomics of antiVEGF in Patients With Age-Associated Macular Degeneration (AMD) Status RECRUITING Phase PHASE3
NCT06888492 To Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in Patients with Wet (neovascular) Age-related Macular Degeneration (wAMD) Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT06875245 Comparing Efficacy of 8-Week and 12-Week Faricimab Initial Follow-Up Treatment Intervals Status RECRUITING Phase PHASE4
NCT06859515 A Long-term Follow up Study of EXG102-031 in Participants With wAMD Status RECRUITING Phase N/A
NCT06556368 A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06518512 Automated Vision Assessment and Impairment Detection Through Gaze Analysis in Wet AMD Patients Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05480293 This Study Will Compare the Efficacy and Safety of SCT510A Administered by Intravitreal Injection (IVT) With Ranibizumab in Patients With wAMD Status UNKNOWN Phase PHASE3
NCT05407636 Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD Status RECRUITING Phase PHASE3
NCT05381948 Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) Status COMPLETED Phase PHASE2
NCT05345236 A Study to Compare QL1207 to Eylea® in Subjects With Wet Age-related Macular Degeneration (wAMD) Status COMPLETED Phase PHASE3
NCT05297292 A Study to Evaluate the Efficacy and Safety of MW02 in the Treatment of nAMD Status UNKNOWN Phase PHASE2/PHASE3
NCT05141994 Clinical Study on the Efficacy and Safety of BAT5906 Injection Status COMPLETED Phase PHASE2
NCT04964089 A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) Status COMPLETED Phase PHASE3
NCT04932980 Comparison of Rapid Aflibercept and Brolucizumab T&E in wAMD Status ACTIVE_NOT_RECRUITING Phase NA
NCT04919096 Study of SCB-420 in Subjects With Neovascular Age-related Macular Degeneration Status WITHDRAWN Phase PHASE1
NCT04884399 Phase I Study to Compare CMAB818 Injection and Lucentis® in Patients With Wet AMD Status COMPLETED Phase PHASE1